Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 10, 2002, Pages 1115-1118

  Peshkin, Beth N ^a   Schwartz, Marc D ^a   Isaacs, Claudine ^a   Hughes, Chanita ^b   Main, David ^a   Lerman, Caryn ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER SCREENING; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HETEROZYGOTE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; ONCOGENE; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GUIDELINE ADHERENCE; HEALTH BEHAVIOR; HUMANS; MAMMOGRAPHY; MIDDLE AGED; ODDS RATIO; PHYSICAL EXAMINATION; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036801350     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lerman, C., Narod, S., Schulman, K., Hughes, C., Gomez-Caminero, A., Bonney, G., Gold, K., Trock, B., Main, D., Lynch, J., Fulmore, C., Snyder, C., Lemon, S. J., Conway, T., Tonin, P, Lenoir, G., and Lynch, H. BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. J. Am. Med. Assoc., 275: 1885-1892, 1996
2. Burke, W., Daly, M., Garber, J., Botkin, J., Kahn, M. J. E., Lynch, P., McTieman, A., Offit, K., Perlman, J., Petersen, G., Thomson, E., and Varricchio, C., for the Cancer Genetics Studies Consortium. Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2. J. Am. Med. Assoc., 277: 997-1003. 1997
3. King, M-C., Wieand, S., Hale, K., Lee, M., Walsh, T., Owens, K., Tait, J., Ford, L., Dunn, B. K., Costantino, J., Wickerham. L., Wolmark. N., and Fisher, B. Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2. National Surgical Adjuvant Breast and Bowel Project (NSABP-PI) Breast Cancer Prevention Trial. J. Am. Med. Assoc., 286: 2251-2256, 2001
4. Questions and Answers about the Study of Tamoxifen and Raloxifene (STAR). National Cancer Institute, Cancer Facts, Fact Sheet 4.19. Bethesda, MD, National Cancer Institute
5. Lerman, C., Hughes, C., Croyle, R. T., Main, D., Durham, C., Snyder, C., Bonney, A., Lynch, J. F., Narod, S. A., and Lynch, H. T. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev. Med., 31: 75-80, 2000
6. Scheuer, L., Kauff, N., Robson, M., Kelly, B., Barakat. R., Satagopan, J., Ellis, N., Hensley, M., Boyd, J., Borgen, P., Norton, L., and Offit, K, Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J. Clin. Oncol., 20: 1260-1268, 2002
7. Isaacs, C., Peshkin, B. N., Schwartz, M., DeMarco, T. A., Main, D., and Lerman, C. Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res. Treat., 71: 103-112, 2002
8. Schwartz, M. D., Hughes, C., Roth. J., Main, D., Peshkin, B. N., Isaacs, C., Kavanagh, C., and Lerman, C. Spiritual faith and genetic testing decisions among high-risk breast cancer probands. Cancer Epidemiol. Biomark. Prev., 9: 381-385, 2000
9. Schwartz, M. D., Peshkin, B. N., Hughes, C., Main, D., Isaacs, C., and Lerman, C. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J. Clin. Oncol., 20: 514-520. 2002
10. Ford, D., Easton, D. F., Stratton. M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude J., Sobol, H., Teare, M. D., Struewing, J., Arason, A., Scherneck, S., Peto, J., Rebbeck. T. R., Tonin, P., Neuhausen, S., Barkardottir, R., Eyfjord, J., Lynch, H., Ponder, B. A., Gayther, S. A., Birch, J. M., Lindblom, A., Stoppa-Lyonnet, D., Bignon, Y., Borg, A., Hamann, U., Haites. N., Scott, R. J., Maugard, C. M., Vasen, H., Seitz, S., Cannon-Albright, L. A., Schofield, A., Zelada-Hedman, M., and the Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet., 62: 676-689, 1998
11. Struewing, J. P., Hartge. P., Wacholder, S., Baker. S. M., Berlin, M., McAdams, M., Timmerman M. M., Brody, L. C., and Tucker, M. A. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N. Engl. J. Med., 336: 1401-1408, 1997
12. Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., Frost, M. H., Grant, C. S., Donohue, J. H., Woods, J. E., McDonnell, S. K., Vockley, C. W., Deffenbaugh, A., Couch, F. J., and Jenkins, R. B. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J. Natl. Cancer Inst. (Bethesda), 93: 1633-1637, 2001
13. Garber, J. E., and Smith, B. L. Management of the high-risk and concerned patient. In: J. R. Harris, M. E. Lippman, M. Morrow, and S. Hellman (eds.), Diseases of the Breast, pp. 323-334. Philadelphia. PA: Lippincott- Raven, 1996
14. Lerman, C., Daly. M., Masny, A., and Balshem. A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J. Clin. Oncol., 12: 843-850, 1994
15. Horowitz, M., Wilner, N., and Alvarez. W. Impact of event scale: a measure of subjective stress. Psychosom. Med., 41: 209-218, 1979
16. King. E. S., Rimer, B. K., Trock. B., Balshem, A., and Engstrom, P. How valid are mammography self-reports? Am. J. Public Health, 80: 1386-1388, 1990
17. Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., Van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff. E., Olopade, O. I., and Weber, B. L., for the Prevention and Observation of Surgical End Points Study Group. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N. Engl. J. Med., 346: 1616-1622, 2002